Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils

European Journal of Immunology

Volumn 28, Issue 7, 1998, Pages 2057-2065

  Luttmann, Werner ^a   Opfer, Alexander ^a   Dauer, Eva ^a   Foerster, Martin ^b   Matthys, Heinrich ^a   Eibel, Hermann ^a   Schulze Osthoff, Klaus ^c   Kroegel, Claus ^b   Virchow, Johann Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Pneumology   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Apoptosis; CD95; Fas ligand; IFN ; TNF

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD95; APOPTOSIS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; FAS LIGAND PROTEIN; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON TYPE II; INTERLEUKIN-3; INTERLEUKIN-5; MEMBRANE GLYCOPROTEINS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031874843     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199807)28:07<2057::AID-IMMU2057>3.0.CO;2-T     Document Type: Article

References (31)

1. Krammer, P. H., Dhein, J., Walczak, H. et al., The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 1994. 142: 175-191.
2. Nagata, S. and Golstein, P., The Fas death factor. Science 1995. 267: 1449-1456.
3. Schulze-Osthoff, K., The Fas/APO-1 receptor and its deadly ligand. Trends Cell Biol. 1994. 4: 421-426.
4. Miyawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S. and Taniguchi, N., Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 1992. 149: 3753-3758.
5. Matsue, H., Kobayashi, H., Hosokawa, T., Akitaya, T. and Ohkawara, A., Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes. Arch. Dermatol. Res. 1995. 287: 315-320.
6. Leithauser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Bruderlein, S., Henne, C., Schmidt, A., Debatin, K. M., Krammer, P. H. and Moller, P., Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 1993. 69: 415-429.
7. Oishi, M., Maeda, K. and Sugiyama, S., Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines. Arch. Dermatol. Res. 1994. 286: 396-407.
8. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, C., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994. 76: 969-976.
9. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992. 356: 314-317.
10. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995. 373: 438-441.
11. Brunner, T., Mogil, R. J., LaFace, D. et al., Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995. 373: 441-444.
12. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A., Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995. 373: 444-448.
13. Simon, H.-U. and Blaser, K., Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol. Today 1995. 16: 53-55.
14. Her, E., Austen, K. F. and Owen, W. F., Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J. Clin. Invest. 1991. 88: 1982-1987.
15. Virchow, J. C., Jr., Walker, C., Hafner, D., Kortsik, C., Werner, P., Matthys, H. and Kroegel, C., T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am. J. Respir. Crit. Care Med. 1995. 151: 960-968.
16. Matsumoto, K., Schleimer, R. P., Saito, H., Iikura, Y. and Bochner, B. S., Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995. 86: 1437-1443.
17. Hebestreit, H., Yousefi, S., Balatti, I., Weber, M., Crameri, R., Simon, D., Hartung, K., Schapowal, A., Blaser, K. and Simon, H. U., Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur. J. Immunol. 1996. 26: 1775-1780.
18. Tsuyuki, S., Bertrand, C., Erard, F., Trifilieff, A., Tsuyuki, J., Wesp, M., Anderson, G. P. and Coyle, A. J., Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J. Clin. Invest. 1995. 96: 2924-2931.
19. Stern, M., Meagher, L., Savill, J. and Haslett, C., Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol. 1992. 148: 3543-3549.
20. Cox, G., Crossley, J. and Xing, Z., Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am. J. Respir. Cell Mol. Biol. 1995. 12: 232-237.
21. Druilhe, A., Cai, Z., Haile, S., Chouaib, S. and Pretolani, M., Fas-mediated apoptosis in cultured human eosinophils. Blood 1996. 87: 2822-2830.
22. Owen-Schaub, L. B., Yonehara, S., Crump, W. L., 3d and Grimm, E. A., DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol. 1992. 140: 197-205.
23. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, R and Lynch, D. H., Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 1993. 178: 2231-2235.
24. Owen-Schaub, L. B., Meterissian, S. and Ford. R. J., Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin. J. Immunother. 1993. 14: 234-241.
25. + T cells. J. Exp. Med. 1993. 177: 573-576.
26. Nakajima, H., Iwamoto, I. and Yoshida, S., Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am. Rev. Respir. Dis. 1993. 148: 1102-1104.
27. Walker, C., Virchow, J. C., Jr., Bruijnzeel, P. L. and Blaser, K., T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. 1991. 146: 1829-1835.
28. Sedgwick, J. B., Calhoun, W. J., Vrtis, R. F., Bates, M. E., McAllister, P. K. and Busse, W. W., Comparison of airway and blood eosinophil function after in vivo antigen challenge. J. Immunol. 1992. 149: 3710-3718.
29. Kato, M., Liu, M. C., Stealey, B. A., Friedman, B., Lichtenstein, L. M., Permutt, S. and Schleimer, R. P., Production of granulocyte/macrophage colony-stimulating factor in human airways during allergen-induced late-phase reactions in atopic subjects. Lymphokine Cytokine Res. 1992. 11: 287-292.
30. Hansel, T. T., De Vries, I. J., Iff, T., Rihs, S., Wandzilak, M., Betz, S., Blaser, K. and Walker, C., An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods 1991. 145: 105-110.
31. Luttmann, W., Knoechel, B., Foerster, M., Matthys, H., Virchow, J. C., Jr. and Kroegel, C., Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. J. Immunol. 1996. 157: 1678-1683.